Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check6 days agoChange DetectedWürzburg University Hospital is added to the Locations section as a study site. The Study Record now shows a last known status that was verified in 2023-12, with the status labeled Unknown.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter updates include removal of HHS Vulnerability Disclosure and Revision: v3.3.2, and addition of Revision: v3.3.3; these are minor site policy/presentation changes that do not alter the study details or how a user would interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision label updated to v3.3.2; the previous v3.3.1 label is no longer displayed.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded 'Revision: v3.3.1' and removed 'Revision: v3.2.0' from the page.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoval of the government funding status notice regarding potential data delays and NIH operations from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03612232. The content appears to be the same as before and the page remains focused on Cabozantinib in Advanced Adrenocortical Carcinoma.SummaryDifference0.5%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.